Angiotensin Converting Enzyme (ACE) Inhibitors Market Overview, Growth Analysis, Trends and Forecast By 2032
Executive Summary The global Angiotensin Converting Enzyme (ACE) inhibitors market size was valued at USD 3.80 billion in 2024 and is expected to reach USD 5.57 billion by 2032 , at a CAGR of 4.90% during the forecast period The Angiotensin Converting Enzyme (ACE) Inhibitors Market is a vital and established segment of the cardiovascular therapeutics landscape. Market growth is structurally driven by the increasing global prevalence of **hypertension, heart failure, and diabetic nephropathy**, particularly within the expanding geriatric population. ACE inhibitors function as a cornerstone therapy by managing the Renin-Angiotensin-Aldosterone System (RAAS), leading to blood vessel relaxation and blood pressure reduction. Despite intense generic competition and the rise of alternative drug classes (ARBs, ARNIs), ACE inhibitors maintain their market dominance due to **strong clinical evidence, cost-effectiveness, and widespread inclusion in firs...